C. Alessandri

发表

Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.

G. Davı̀, S. Basili, M. Vieri, 1997, American journal of respiratory and critical care medicine.

Preparation and biodistribution of 99m technetium labelled oxidized LDL in man.

G. Ronga, P. Fiorani, C. Alessandri, 1996, Atherosclerosis.

Elasticity/distensibility of the ascending aorta: basal conditions and simulated conditions from space flights.

C. Alessandri, E. Tomao, N. Alessandri, 2010, European review for medical and pharmacological sciences.

Serum Metalloproteinase 9 Levels in Patients with Coronary Artery Disease: A Novel Marker of Inflammation

F. Ceci, S. Basili, C. Alessandri, 2003, Journal of Investigative Medicine.

Multifactorial therapeutic approach to secondary prevention in coronary heart disease: Preliminary report after 3-year follow-up

S. Basili, C. Alessandri, C. Cordova, 1994 .

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

C. Alessandri, A. Tincani, G. Valesini, 2004, Annals of the rheumatic diseases.

Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor b in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension

C. Alessandri, C. Vizza, G. Valesini, 2015 .

Functional changes cardiovascular: normobaric activity and microgravity in young healthy human subjects.

C. Alessandri, E. Tomao, N. Alessandri, 2012, European review for medical and pharmacological sciences.

Lipoprotein (a) serum levels in patients with hepatocarcinoma.

S. Basili, M. Vieri, C. Alessandri, 1997, Clinica chimica acta; international journal of clinical chemistry.

Lipoprotein (a) does not influence hyperfibrinolysis in patients with liver cirrhosis

S. Basili, C. Alessandri, C. Cordova, 1995 .

Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

S. Basili, C. Alessandri, C. Cordova, 1992, Hepatology.

Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs

C. Alessandri, V. Manganelli, G. Valesini, 2019, Arthritis Research & Therapy.

Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease.

G. Labbadia, F. Ceci, S. Basili, 1999, Atherosclerosis.

Influence of ascorbic acid on platelet aggregation in vitro and in vivo.

C. Alessandri, C. Cordova, F. Violi, 1982, Atherosclerosis.

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.

C. Alessandri, F. Lirussi, M. del Ben, 2013, The Cochrane database of systematic reviews.

Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases

C. Alessandri, T. Antonini, M. del Ben, 2003, Journal of gastroenterology and hepatology.

Hypercoagulability State in Patients with Chronic Obstructive Pulmonary Disease

S. Basili, C. Alessandri, P. Gazzaniga, 1994, Thrombosis and Haemostasis.

The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort

C. Alessandri, G. Valesini, F. Spinelli, 2016, Lupus.

Thin‐layer chromatography immunostaining in detecting anti‐phospholipid antibodies in seronegative anti‐phospholipid syndrome

G. Hughes, M. Khamashta, C. Alessandri, 2012, Clinical and experimental immunology.

Anti‐lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus

G. Labbadia, L. D. Di Prospero, P. Conigliaro, 2005, Clinical and experimental immunology.

Ultrasonographic depiction of knee joint alterations in systemic lupus erythematosus.

A. Iagnocco, C. Alessandri, R. Priori, 2009, Clinical and experimental rheumatology.

Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age.

C. Alessandri, G. Valesini, R. Paganelli, 2009, Archives of gerontology and geriatrics.

Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study.

A. Iagnocco, C. Alessandri, R. Priori, 2004, Clinical and experimental rheumatology.

A Case Report of Intrahepatic Cholangiocarcinoma in a Young Male

A. Laghi, C. Alessandri, V. Petrozza, 2015 .

Effect of simvastatin treatment on high-density lipoprotein cholesterol

S. Basili, C. Alessandri, C. Cordova, 1992 .

Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.

S. Basili, C. Alessandri, C. Cordova, 1996, Journal of hepatology.

Intravascular clotting activation and systemic hyperfibrinolysis in patients with severe liver cirrhosis: The role of ascites

S. Basili, C. Alessandri, F. Violi, 1994 .

Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change.

C. Alessandri, C. Della Rocca, C. di Cristofano, 2009, European review for medical and pharmacological sciences.

Proinflammatory cytokines and hemostatic system in patients with chronic obstructive pulmonary disease.

S. Basili, M. Vieri, C. Alessandri, 1997, Platelets.

Biological therapies in rheumatic diseases.

C. Alessandri, R. Scrivo, M. Di Franco, 2013, La Clinica terapeutica.

Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.

G. Labbadia, S. Basili, M. Vieri, 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

EFFECTS OF HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS ON SOME BLOOD COAGULATION PARAMETERS

S. Basili, C. Alessandri, C. Cordova, 1993 .

Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate.

D. Praticò, C. Alessandri, F. Violi, 1989, Thrombosis research.

Influence of hydroxyl radical scavengers on platelet function.

C. Alessandri, C. Cordova, F. Violi, 1988, Haemostasis.

Relationship between prothrombin activation fragment F1 + 2 and serum cholesterol.

S. Basili, C. Alessandri, C. Cordova, 1996, Haemostasis.

Y chromosome microchimerism in Sjögren's syndrome

A. Stoppacciaro, C. Alessandri, F. Carlucci, 2001, Annals of the rheumatic diseases.

Leukocyte response in patients suffering from acute stroke.

C. Alessandri, F. Violi, D. Intiso, 1988, Stroke.

The effects of gliclazide on platelet function in patients with diabetes mellitus.

C. Alessandri, F. Violi, A. Perrone, 1982, Current medical research and opinion.

AB1170 Prevalence of anti-carp antibodies in patients with primary sjÖgren's syndrome: association with clinical, serological and histological aspects

C. Alessandri, R. Priori, G. Valesini, 2017 .

Platelet Activation in Hypercholesterolemic Patients Submitted to Therapeutic Plasmapheresis. An Ultrastructural Study.

C. Alessandri, G. Bianciardi, G. Ricci, 1997, Hematology.

Still ' s disease Lymph node IL-18 expression in adult-onset

I. McInnes, C. Alessandri, G. Valesini, 2010 .

Lymph node IL-18 expression in adult-onset Still’s disease

P. Conigliaro, I. McInnes, C. Alessandri, 2009, Annals of the rheumatic diseases.

Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicals

C. Alessandri, L. Iuliano, A. Ghiselli, 1989, Lipids.

[Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis].

A. Iagnocco, C. Alessandri, G. Valesini, 2011, Reumatismo.

Rheumatoid arthritis-etiology, pathogenesis and animal models

C. Alessandri, G. Valesini, M. Di Franco, 2022 .

Platelet hyperfunction in patients with chronic airways obstruction.

C. Alessandri, C. Cordova, F. Violi, 1985, European journal of respiratory diseases.

Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood.

D. Praticò, C. Alessandri, F. Violi, 1993, The American journal of physiology.

Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease.

S. Basili, C. Alessandri, P. Gazzaniga, 1996, Thrombosis research.

In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease.

S. Basili, C. Alessandri, P. Gazzaniga, 1994, Platelets.

LONG-TERM OXYGEN AND ADVANCED CHRONIC BRONCHITIS

C. Alessandri, C. Cordova, F. Violi, 1981, The Lancet.

CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients

R. Perricone, C. Alessandri, G. Valesini, 2019, Lupus.

Prekallikrein and factor VII as prognostic indexes of liver failure.

C. Alessandri, C. Cordova, F. Violi, 1986, American journal of clinical pathology.

Streptococcal–vimentin cross‐reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease

M. Crescenzi, S. Camerini, C. Alessandri, 2013, Clinical and experimental immunology.

Plasma thiobarbituric acid reactive substances a predictive marker of cerebral ischemia in patients at high risk?

C. Alessandri, F. Violi, A. Ghiselli, 1991, Acta neurologica Scandinavica.

Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with mild hypercholesterolemia.

C. Alessandri, F. Violi, M. del Ben, 2006, Arteriosclerosis, thrombosis, and vascular biology.

LIVER, PANCREAS, AND BILIARY TRACT Association Between Low-Grade Disseminated Intravascular Coagulation and Endotoxemia in Patients With Liver Cirrhosis

S. Basili, C. Alessandri, C. Cordova, 1995 .

Blood lipid profile in healthy subjects treated with ticlopidine.

C. Alessandri, F. Violi, L. Iuliano, 1985, Atherosclerosis.

Inhibition by picotamide of thromboxane production in vitro and ex vivo

D. Praticò, C. Alessandri, F. Violi, 2004, European Journal of Clinical Pharmacology.

Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.

D. Praticò, C. Alessandri, C. Cordova, 1990, Atherosclerosis.

Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A

C. Alessandri, R. Priori, G. Valesini, 2000, Lupus.

Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

C. Alessandri, C. Vizza, G. Valesini, 2015, Reumatismo.

Activation of platelet cyclooxygenase by red cells in vitro.

C. Alessandri, F. Violi, L. Iuliano, 1985, The New England journal of medicine.

1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression model.

S. Basili, C. Alessandri, C. Cordova, 1992, Scandinavian journal of gastroenterology.

Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis.

C. Alessandri, C. Cordova, F. Violi, 1989, Journal of clinical pathology.

Beta-Thromboglobulin Plasma Levels in Common Migraine

C. Alessandri, F. Violi, L. Iuliano, 1984, Thrombosis and Haemostasis.

Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material

C. Alessandri, C. Cordova, F. Violi, 1985, Lipids.

Blood lipid peroxides in TIA: relation to platelet function and metabolic profile

C. Alessandri, F. Violi, A. Ghiselli, 1989, Acta neurologica Scandinavica.

Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13

C. Alessandri, R. Scrivo, G. Valesini, 2002, Annals of the rheumatic diseases.

A simple method for evaluating platelet superoxide dismutase.

C. Alessandri, F. Violi, L. Iuliano, 1985, Scandinavian journal of clinical and laboratory investigation.

Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis.

S. Basili, C. Alessandri, C. Cordova, 1995, Gastroenterology.

Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterization.

C. Alessandri, F. Bartoli, W. Marconi, 1979, Transactions - American Society for Artificial Internal Organs.

Leishmania in SLE mimicking an exacerbation.

C. Alessandri, G. Valesini, F. Conti, 2006, Clinical and experimental rheumatology.

Low Doses of Calcium-Heparin in Liver Cirrhosis

C. Alessandri, C. Cordova, F. Violi, 1985, Thrombosis and Haemostasis.

Association between High Values of D-dimer and Tissue-plasminogen Activator Activity and First Gastrointestinal Bleeding in Cirrhotic Patients

S. Basili, C. Alessandri, C. Cordova, 1996, Thrombosis and Haemostasis.

Dilute aPTT Prolongation by Antiphospholipid Antibodies in Patients with Liver Cirrhosis

C. Alessandri, F. Violi, G. Valesini, 1990, Thrombosis and Haemostasis.

Evaluation of D-Dimer in Patients with Liver Cirrhosis

C. Alessandri, D. Ferro, C. Quintarelli, 1989, Thrombosis and Haemostasis.

Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.

C. Alessandri, C. Cordova, F. Violi, 1986, Journal of clinical pathology.

Blood coagulation consumption in a patient with autoimmune chronic active hepatitis.

C. Alessandri, F. Violi, L. Iuliano, 1984, Haematologica.

Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin.

C. Alessandri, C. Cordova, F. Violi, 2009, Scandinavian journal of haematology.

Inhibition of Tissue Plasminogen Activator Inhibitor by Defibrotide in Atherosclerotic Patients

C. Alessandri, F. Violi, F. Balsano, 1989, Seminars in thrombosis and hemostasis.

Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.

C. Alessandri, C. Cordova, F. Violi, 1984, Haemostasis.

Prevalence of hyperfibrinolysis in patients with liver cirrhosis

S. Basili, C. Alessandri, F. Violi, 1993 .

Fibrinopeptide A behaviour in chronic active hepatitis patients.

C. Alessandri, F. Violi, L. Iuliano, 1984, Haematologica.

Correlation between hepatic blood flow and coagulation indices in chronic active hepatitis and liver cirrhosis patients.

C. Alessandri, F. Violi, F. Balsano, 1985, Haemostasis.

Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus

B. Marinari, M. Falchi, P. Romero, 2020, Scientific Reports.

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia.

S. Basili, C. Alessandri, F. Violi, 2000, Journal of the American College of Cardiology.

Inhibition of tissue-factor-mediated thrombin generation by simvastatin.

S. Basili, C. Alessandri, F. Violi, 2000, Atherosclerosis.

IL-6-Producing, Noncatecholamines Secreting Pheochromocytoma Presenting as Fever of Unknown Origin

A. Laghi, C. Alessandri, L. Iuliano, 2016, Case reports in medicine.

Reply to: Lipoprotein (a) and chronic obstructive pulmonary disease.

S. Basili, C. Alessandri, P. Gazzaniga, 2001, Atherosclerosis.

Soluble P-Selectin and Proinflammatory Cytokines in Patients with Polygenic Type IIa Hypercholesterolemia

G. Labbadia, S. Basili, M. Vieri, 2000, Pathophysiology of Haemostasis and Thrombosis.

A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication

G. Novelli, P. Borgiani, C. Alessandri, 2017, Lupus.

Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation

C. Alessandri, F. Violi, R. Cangemi, 2006, Diabetologia.

Improvement of blood gas levels after calcium-heparin treatment in patients with chronic obstructive pulmonary disease.

S. Basili, C. Alessandri, C. Cordova, 1992, Thrombosis research.

THU0054 Reduction of il-18 serum levels in rheumatoid arthritis during short term-treatment with infliximab

C. Alessandri, R. Scrivo, G. Valesini, 2001 .

Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients.

C. Alessandri, C. Cordova, F. Violi, 1984, Clinica chimica acta; international journal of clinical chemistry.

Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis.

S. Basili, C. Alessandri, C. Cordova, 1994, Clinica chimica acta; international journal of clinical chemistry.

Frailty and disability in the elderly: a diagnostic dilemma.

C. Alessandri, A. Vestri, C. Alessandri, 2011, Archives of gerontology and geriatrics.

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia

S. Basili, C. Alessandri, C. Cordova, 1997, The Lancet.

Frailty in patients affected by atrial fibrillation.

C. Alessandri, A. Pacelli, M. Ciacciarelli, 2013, Archives of gerontology and geriatrics (Print).

Hydrogen peroxide as trigger of platelet aggregation.

D. Praticò, C. Alessandri, F. Violi, 1991, Haemostasis.

Influence of Vitamin E on Plasma Malondialdehyde- Like Material in Man

C. Alessandri, C. Cordova, F. Violi, 1984, Thrombosis and Haemostasis.

Effects of Ticlopidine on Platelet Function and Blood Coagulation

C. Alessandri, F. Violi, A. Ghiselli, 1982, Thrombosis and Haemostasis.

Superoxide Anion Scavenging Property of Dipyridamole

C. Alessandri, F. Violi, L. Iuliano, 1989, Thrombosis and Haemostasis.

FRI0121 STEROID-SPARING EFFECT OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS FOLLOWED UP IN A REAL LIFE SETTING

C. Alessandri, R. Scrivo, R. Priori, 2020 .

Interleukin‐36α axis is modulated in patients with primary Sjögren's syndrome

C. Alessandri, S. Raimondo, R. Priori, 2015, Clinical and experimental immunology.

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.

C. Alessandri, F. Violi, M. Cavallo, 2005, The Journal of clinical endocrinology and metabolism.

Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT

C. Alessandri, G. Reboldi, G. Valesini, 2014, Lupus.

[Relationship between blood fibrinogen and plasma lipoproteins in patients with hypercholesterolemia].

C. Cancrini, S. Basili, M. Vieri, 1994, Minerva medica.

Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort

C. Alessandri, G. Valesini, E. Moscarelli, 2018, Lupus.

Lipoprotein and Hemocoagulatory Parameters during Therapeutic Plasmapheresis in Homozygous and Heterozygous Familial Hypercholesterolemia

C. Alessandri, G. Bianciardi, C. Colombo, 1993 .

OP0069 Microchimerism and sjÖgren? s syndrome: a preliminary study on salivary glands

A. Stoppacciaro, C. Alessandri, F. Carlucci, 2001 .

High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.

S. Basili, C. Alessandri, C. Cordova, 1992, La Clinica terapeutica.

Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score

C. Alessandri, G. Valesini, F. Spinelli, 2019, Lupus.

Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio.

C. Alessandri, G. Valesini, F. Spinelli, 2015, Reumatismo.

Antibodies to age‐β2glycoprotein I in patients with anti‐phospholipid antibody syndrome

F. Facchiano, C. Alessandri, G. Valesini, 2015, Clinical and experimental immunology.

Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes.

C. Alessandri, G. Valesini, P. Pozzilli, 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Serum Metalloproteinase 9 Levels in Patients with Coronary Artery Disease: A Novel Marker of Inflammation

F. Ceci, S. Basili, C. Alessandri, 2003, Journal of Investigative Medicine.

Apolipoproteins C-II and C-III in Peripheral Arterial Disease

S. Basili, C. Alessandri, C. Cordova, 1994, Angiology.

Human platelet aggregation by PAF and thromboxane production.

D. Praticò, C. Alessandri, C. Cordova, 1987, Thrombosis research.

Frailty in patients affected by atrial fibrillation.

C. Alessandri, A. Pacelli, M. Ciacciarelli, 2013, Archives of gerontology and geriatrics.

[Effects of medium- and long-term treatment with nicardipine on arterial blood pressure, hemodynamics and renal function in patients with arterial hypertension of mild and moderate degree].

C. Alessandri, C. Ferri, A. Santucci, 1988, La Clinica terapeutica.